CANNABIS USE DISORDER: FRIEND OR FOE IN SEPTIC SHOCK AND ASSOCIATED MORTALITY AMONG GERIATRIC SEPSIS PATIENTS WITH CHRONIC KIDNEY OR LIVER DISEASE?
نویسندگان
چکیده
TOPIC: Critical Care TYPE: Original Investigations PURPOSE: With the increasing medicinal use of cannabis and potential anti-inflammatory role, we aimed to assess odds in-hospital mortality septic shock with vs. without among geriatric sepsis patients chronic kidney or liver diseases (CKD/CLD) using a nationally representative cohort. METHODS: We queried National Inpatient Sample (2017) identify concomitant CKD/CLD complicated by shock. Primary outcomes (septic associated inpatient mortality) secondary (patient discharge length stay) were compared between users non-users. Multivariable analysis was performed adjusting for confounders mortality. A propensity score-matched confirm observed in unmatched cohorts. two-sided p-value<0.05 considered statistically significant. RESULTS: Of 675,850 admissions CKD/CLD, 146,915 (21.7%) experienced these, 90 users. Cannabis relatively younger (69 [66-73]), males (77.8% vs 53%) (p<0.001) Both cohorts had higher proportion white (>60%) often admitted non-electively (>88%). more frequently demonstrated alcohol abuse (22.2% 1.9%, p<0.001), coagulopathy (33.3% 22.5%, p=0.014), drug (38.9% 0.8%, pulmonary disease (44.4% 20.0%, showed lower frequency hypertension (72.2% 81.4%, p=0.025) diabetes mellitus (16.7% 32.2%, p=0.002) did not decrease risk on unadjusted (OR:0.90 95%CI:0.71-1.13, p=0.371) adjusted (demographics+hospital characteristics:OR:0.82 95%CI:0.65-1.04, p=0.100; plus comorbidities:OR:0.88 95%CI:0.69-1.13, p=0.325) regression but it significantly reduced septic-shock (OR:0.39 95%CI:0.22-0.67, p=0.001) characteristics:OR:0.25, 95%CI:0.13-0.49, p<0.001; comorbidities:OR:0.30 95%CI:0.15-0.59, p<0.001) multivariable analyses. Propensity-matched shock-cannabis (90) shock-nonusers (85) also confirmed 47.1%, p<0.001). discharged routinely (61.1% 48.5%, extended stay (8 7 days) hospital charges ($18,800 18,225$) non-users (p<0.05). CONCLUSIONS: affect developing even after confounders. Potential therapeutic application high-risk can be explored future prospective studies evaluate association mode, dose duration outcomes. CLINICAL IMPLICATIONS: The finding this study warrants explore role underlying which is encountered critical care settings. DISCLOSURES: No relevant relationships Ummul Asfeen, source=Web Response Harika Varma Chintalapalli Patta, Rupak Desai, Bushra Fatima, Zainab Gandhi, Praneeth Reddy Keesari, Taherunnisa Rida, Sashwath Srikanth, Nibras Yar Khan,
منابع مشابه
Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
Many studies have shown evidence that erythropoiesis-stimulating agents (ESAs), as a classic treatment for chronic kidney disease (CKD)-related anemia, have several disadvantages and may trigger various adverse events with long-term use. The hypoxia-induced factor (HIF) pathway has been intensively investigated in kidney disease, especially in CKD, as research has shown that HIF-mediated erythr...
متن کاملVegetarian Diet in Chronic Kidney Disease—A Friend or Foe
Healthy diet is highly important, especially in patients with chronic kidney disease (CKD). Proper nutrition provides the energy to perform everyday activities, prevents infection, builds muscle, and helps to prevent kidney disease from getting worse. However, what does a proper diet mean for a CKD patient? Nutrition requirements differ depending on the level of kidney function and the presence...
متن کاملClinical review: Fever in septic ICU patients - friend or foe?
In recent years, fever control in critically ill patients by medications and/or external cooling has gained widespread use, notably in patients suffering from neurological injuries. Nevertheless, such a strategy in septic patients is not supported by relevant data. Indeed, in response to sepsis, experimental and clinical studies argue that fever plays a key role in increasing the clearance of m...
متن کاملStatins and the Kidney: Friend or Foe?
Statins essentially are cholesterol-lowering drugs that are extensively prescribed for primary and secondary prevention of cardiovascular disease. Compelling evidence suggests that the beneficial effects of statins may not only be due to controlling cholesterol levels but also due to a pleiotropic cholesterol-independent anti-inflammatory, antioxidant, endothelial-protective and plaque-stabiliz...
متن کاملStatins and the kidney: friend or foe?
Statins essentially are cholesterol-lowering drugs that are extensively prescribed for primary and secondary prevention of cardiovascular disease. Compelling evidence suggests that the beneficial effects of statins may not only be due to controlling cholesterol levels but also due to a pleiotropic cholesterol-independent anti-inflammatory, antioxidant, endothelial-protective and plaque-stabiliz...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2021
ISSN: ['0012-3692', '1931-3543']
DOI: https://doi.org/10.1016/j.chest.2021.07.1019